Vyne Therapeutics Inc (VYNE)

06:00 AM

Is VYNE Therapeutics Inc. stock poised for growth2025 Trade Ideas & Fast Gain Swing Alerts - Newser

06:00 AM

05:53 AM

Tools to assess VYNE Therapeutics Inc.’s risk profileDay Trade & Expert Approved Trade Ideas - Newser

05:53 AM

03:50 AM

How Resilient Is VYNE Therapeutics Inc. Stock During Economic DownturnsTake Profit & Fast Entry High Yield Tips - Newser

03:50 AM

03:36 AM

Price action breakdown for VYNE Therapeutics Inc.July 2025 Recap & Advanced Technical Signal Analysis - Newser

03:36 AM

03:00 AM

VYNE Therapeutics Inc. (NASDAQ:VYNE) Short Interest Up 526.7% in July - Defense World

03:00 AM

02:49 AM

Is VYNE Therapeutics Inc. reversing from oversold territory2025 Volatility Report & Weekly Top Gainers Trade List - Newser

02:49 AM

02:43 AM

Is VYNE Therapeutics Inc. stock entering bullish territoryJuly 2025 Trade Ideas & Safe Capital Growth Stock Tips - Newser

02:43 AM

Aug 15, 2025

Risk vs reward if holding onto VYNE Therapeutics Inc.Market Weekly Review & Daily Volume Surge Signals - Newser

Aug 15, 2025

Aug 15, 2025

VYNE Therapeutics Inc. (VYNE) Reports Q2 Loss, Lags Revenue Estimates - MSN

Aug 15, 2025

Aug 15, 2025

VYNE Stock Update: VYNE Therapeutics Inc’s Banking’s Market Struggles and Potential Opportunities - investchronicle.com

Aug 15, 2025

Aug 15, 2025

VYNE 2025 Q2 Earnings Losses Narrow Despite Sharp Revenue Drop - AInvest

Aug 15, 2025

Aug 15, 2025

VYNE Therapeutics Reports Q2 2025 Financials and Updates - TipRanks

Aug 15, 2025

Aug 14, 2025

Will breakout in VYNE Therapeutics Inc. lead to full recoveryEntry Point & Verified Momentum Watchlists - Newser

Aug 14, 2025

Aug 14, 2025

Vitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - GlobeNewswire Inc.

Aug 14, 2025

Aug 14, 2025

VYNE Therapeutics Reports 2025 Second Quarter Financial Results and Provides Business Update | VYNE Stock News - GuruFocus

Aug 14, 2025

Aug 14, 2025

VYNE (VYNE) reports quarter results; two directors resign - Stock Titan

Aug 14, 2025

Aug 14, 2025

VYNE Therapeutics Reports 2025 Second Quarter Financial Results and Provides Business Update - MarketScreener

Aug 14, 2025

Aug 14, 2025

VYNE's Psoriasis Drug Shows Promise as FDA Partially Lifts Clinical Hold, Cash Position Strengthens - Stock Titan

Aug 14, 2025

Aug 13, 2025

Does VYNE Therapeutics Inc. stock pay reliable dividendsRecession Risk & AI Based Trade Execution Alerts - Newser

Aug 13, 2025

Aug 12, 2025

Is VYNE Therapeutics Inc. trending in predictive chart modelsConservative Investment Setup and Risk Analysis - Newser

Aug 12, 2025

Aug 12, 2025

Volume Surge May Signal Institutional Interest in VYNE Therapeutics Inc.Breakout Confirmation With Entry Tracker Enabled - 선데이타임즈

Aug 12, 2025

Aug 12, 2025

Technical analysis overview for VYNE Therapeutics Inc. stockSector Rotation and Stock Opportunity Analysis - Newser

Aug 12, 2025

Aug 11, 2025

What makes VYNE Therapeutics Inc. stock price move sharplyStrong ROI Equity Ideas - thegnnews.com

Aug 11, 2025

Aug 11, 2025

Aquestive Therapeutics Q2 Earnings Miss Estimates, Revenue Down 50% YoY - AInvest

Aug 11, 2025

Aug 11, 2025

VYNE Therapeutics (VYNE) Projected to Post Quarterly Earnings on Wednesday - Defense World

Aug 11, 2025

Aug 10, 2025

Does VYNE Therapeutics Inc. show high probability of reboundTechnical Trade Plan with Entry Checklist - Newser

Aug 10, 2025

Aug 10, 2025

Will earnings trigger a reversal in VYNE Therapeutics Inc.Free Weekly Hot Picks With Buy Confidence - Newser

Aug 10, 2025

Aug 09, 2025

A Quick Look at Today's Ratings for VYNE Therapeutics(VYNE.US), With a Forecast Between $2 to $2 - 富途牛牛

Aug 09, 2025

Aug 08, 2025

Vyne Therapeutics Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView

Aug 08, 2025

Aug 07, 2025

How to read the order book for VYNE Therapeutics Inc.Equity Performance Forecast Based on AI Models - Newser

Aug 07, 2025

Aug 06, 2025

Chart based exit strategy for VYNE Therapeutics Inc.Earnings Impact and Stock Reaction Analysis - Newser

Aug 06, 2025